Trial Profile
A study on the safety and efficacy of tolvaptan for patients with fluid retention after cardiothoracic surgery
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Aug 2017
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 21 Aug 2013 New trial record